Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
SHANGHAI PECHEM
00338
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 0 | 1.97K | ||||||||
| Gross profit | 0 | -1.97K | ||||||||
| Operating expense | -23.86%368.57K | -26.68%90.05K | -36.48%94.23K | -27.52%75.63K | 3.26%112.1K | 39.00%484.07K | 55.80%122.81K | 78.85%148.35K | 23.21%104.35K | 6.65%108.56K |
| Selling and administrative expenses | -24.26%365.12K | -28.33%86.6K | -36.48%94.23K | -27.52%75.63K | 0.09%108.66K | 38.43%482.1K | 53.30%120.84K | 78.85%148.35K | 23.21%104.35K | 6.65%108.56K |
| -General and administrative expense | -24.26%365.12K | -28.33%86.6K | -36.48%94.23K | -27.52%75.63K | 0.09%108.66K | 38.43%482.1K | 53.30%120.84K | 78.85%148.35K | 23.21%104.35K | 6.65%108.56K |
| Other operating expenses | 75.27%3.44K | ---- | ---- | ---- | --3.44K | --1.97K | ---- | ---- | ---- | ---- |
| Operating profit | 23.86%-368.57K | 28.33%-86.6K | 37.31%-94.23K | 27.52%-75.63K | -3.26%-112.1K | -39.00%-484.07K | -53.30%-120.84K | -81.22%-150.32K | -23.21%-104.35K | -6.65%-108.56K |
| Net non-operating interest income (expenses) | ||||||||||
| Other net income (expenses) | 24,401.54%286.91K | -189.23%-752 | -565.50%-1.46K | -71.81%515 | 40,806.21%288.61K | 108.21%1.17K | 97.52%-260 | 124.32%313 | 208.30%1.83K | 13.85%-709 |
| Gain on sale of security | -346.54%-2.89K | -189.23%-752 | -565.50%-1.46K | -71.81%515 | -68.27%-1.19K | 108.21%1.17K | 97.52%-260 | 124.32%313 | 208.30%1.83K | 13.85%-709 |
| Special income (charges) | --289.8K | --0 | --0 | --0 | --289.8K | --0 | --0 | --0 | --0 | ---- |
| -Less:Other special charges | ---289.8K | --0 | ---- | ---- | ---289.8K | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 83.09%-81.65K | 27.87%-87.36K | 36.21%-95.69K | 26.73%-75.11K | 261.54%176.51K | -33.21%-482.9K | -35.63%-121.1K | -78.08%-150K | -18.69%-102.52K | -6.48%-109.27K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 83.09%-81.65K | 27.87%-87.36K | 36.21%-95.69K | 26.73%-75.11K | 261.54%176.51K | -33.21%-482.9K | -35.63%-121.1K | -78.08%-150K | -18.69%-102.52K | -6.48%-109.27K |
| Net income continuous operations | 83.09%-81.65K | 27.87%-87.36K | 36.21%-95.69K | 26.73%-75.11K | 261.54%176.51K | -33.21%-482.9K | -35.63%-121.1K | -78.08%-150K | -18.69%-102.52K | -6.48%-109.27K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 83.09%-81.65K | 27.87%-87.36K | 36.21%-95.69K | 26.73%-75.11K | 261.54%176.51K | -33.21%-482.9K | -35.63%-121.1K | -78.08%-150K | -18.69%-102.52K | -6.48%-109.27K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 83.09%-81.65K | 27.87%-87.36K | 36.21%-95.69K | 26.73%-75.11K | 261.54%176.51K | -33.21%-482.9K | -35.63%-121.1K | -78.08%-150K | -18.69%-102.52K | -6.48%-109.27K |
| Diluted earnings per share | 0 | 0 | 0 | 0 | 314.50%0.01 | 0.00%-0.02 | 0.00%-0.01 | -178.24%-0.01 | 0 | -6.49%-0.0047 |
| Basic earnings per share | 0 | 0 | 0 | 0 | 314.50%0.01 | 0.00%-0.02 | 0.00%-0.01 | -178.24%-0.01 | 0 | -6.49%-0.0047 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.